(BCR) C.R. Bard – Bull of the Day

C.R. Bard (BCR) operates in vascular, urology, oncology and surgical specialty markets. These end-markets should remain insulated from the current economic turmoil.

Many of the company’s products are used in interventional medicine — life-saving surgical procedures. Future quarters will be met with a headwind from foreign exchange.

However, with less than a third of sales outside of the United States, the impact will be less than that for BCR’s competitors.

We retain our Outperform rating on the shares.

Zacks Investment Research
View original at: Zacks.com News Feed


Similar Posts: | | Healthcare | Medical Instruments & Supplies

RSS feeds: BCR | Cr Bard Inc | Healthcare | Medical Instruments & Supplies |

Other Posts by vitalstocks | RSS Feed for this author

Post a Response

You must be logged in to post a comment.